Back
Sage Therapeutics Stock Price Chart

One Tool. Personalized Setups.
Try it here.
Sell
50
SAGE
Sage Therapeutics
Last Price:
$9.09
Seasonality Move:
-6.64%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
The current trend is moderately bullish and SAGE is experiencing selling pressure, which indicates risk of future bearish movement.
Sage Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.19 | Sell |
20-day SMA: | 8.21 | Buy |
50-day SMA: | 7.46 | Buy |
200-day SMA: | 6.97 | Buy |
8-day EMA: | 9.03 | Buy |
20-day EMA: | 8.44 | Buy |
50-day EMA: | 7.79 | Buy |
200-day EMA: | 8.38 | Buy |
Sage Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.61 | Buy |
Relative Strength Index (14 RSI): | 71.54 | Buy |
Chaikin Money Flow: | -943570 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.61 - 9.13) | Buy |
Bollinger Bands (100): | (6.68 - 8.28) | Buy |
Sage Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Sage Therapeutics Stock
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 9.08 while SAGE 8-day simple moving average is 9.19, which is a Sell signal.
-
The stock price of SAGE is 9.08 while Sage Therapeutics 20-day SMA is 8.21, which makes it a Buy.
-
Sage Therapeutics 50-day simple moving average is 7.46 while SAGE share price is 9.08, making it a Buy technically.
-
SAGE stock price is 9.08 and Sage Therapeutics 200-day simple moving average is 6.97, creating a Buy signal.
SAGE Technical Analysis vs Fundamental Analysis
Sell
50
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy or a Sell?
-
Sage Therapeutics stock is rated a SellThe current Sage Therapeutics [SAGE] share price is $9.08. The Score for SAGE is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Sage Therapeutics Stock Info
Market Cap:
568.6M
Price in USD:
9.08
Share Volume:
1.5M
Sage Therapeutics 52-Week Range
52-Week High:
13.47
52-Week Low:
4.62
Sell
50
Sage Therapeutics (SAGE)
is a Sell
Sage Therapeutics Share Price Forecast
-
What is the Sage Therapeutics stock price today?The Sage Therapeutics stock price is 9.08 USD today.
-
Will SAGE stock go up or go down?Sage Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sage Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sage Therapeutics is overvalued.
Is Sage Therapeutics Stock a Buy?
-
Sage Therapeutics share price is 9.08 while SAGE 8-day exponential moving average is 9.03, which is a Buy signal.
-
The stock price of SAGE is 9.08 while Sage Therapeutics 20-day EMA is 8.44, which makes it a Buy.
-
Sage Therapeutics 50-day exponential moving average is 7.79 while SAGE share price is 9.08, making it a Buy technically.
-
SAGE stock price is 9.08 and Sage Therapeutics 200-day simple moving average is 8.38, creating a Buy signal.
Fundamental Analysis of Sage Therapeutics
Is Sage Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.69 per share, an increase next quarter of $0.42 per share, an increase this year of $2.76 per share, and an increase next year of $0.46 per share.
Technical Analysis of Sage Therapeutics
Should I short Sage Therapeutics stock?
-
SAGE Moving Average Covergence Divergence (MACD) indicator is 0.61, suggesting Sage Therapeutics is a Buy
-
Sage Therapeutics Relative Strength Index (RSI) is 71.54, which suggest Sage Therapeutics is overbought
-
The Bollinger Bands (25) for Sage Therapeutics is (6.61 - 9.13), which suggest Sage Therapeutics is a Buy
-
The Bollinger Bands (100) for Sage Therapeutics is (6.68 - 8.28), which suggest Sage Therapeutics is a Buy
* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.